128 signals · bluesky, h1b_lca, newsapi +1 more
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Moderate stress signals detected across available public data.
Moderate risk indicators present across data sources.
Signal data from 2 sources places Amgen in the Biotechnology space at moderate workforce stress signals with moderate risk indicators.
Signals for Amgen were collected from 2 sources. Aggregate signal sentiment appears mixed or neutral. The stress score stands at 48/100 with a risk score of 64/100. Signal coverage is sufficient to support a preliminary assessment.
Amgen hit with lawsuit over its proposed Opdivo biosimilar lifesciencesipreview.com
Amgen won a court order pausing Colorado’s $600-a-dose cap on Enbrel, an arthritis drug the average plan there paid about $53,000 a year for. Resistbot is asking your state lawmakers and everyone running for those seats to create a drug affordability board that can cap prices like that.
Amgen won a court order pausing Colorado’s $600-a-dose cap on Enbrel, an arthritis drug the average plan there paid about $53,000 a year for.
Biotechnology company focused on human biology.
Based on 128 signals across 4 sources · snapshot 17 Sept 2026
Strong — enough signals from diverse sources to trust this score.
Overall community sentiment for Amgen is mixed based on public signals as of 17 Sept 2026.
Based on 128 signals across 4 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
What this means
Mixed signals with moderate levels across the board. No strong directional trend.
AI-generated from public signals — may be incomplete. Based on 4 recent signals.
This summary is generated from publicly available review and signal data. It is intended as an indicative overview only and should not be used as the sole basis for employment, investment, or business decisions. Signal volume and source diversity may limit representativeness.
AI summaries are generated from public signals and may not reflect the full picture.
Amgen Partners with Veeva to Scale Global Implementation of Vault CRM #USA #Veeva_Systems #Amgen #Pleasanton #Vault_CRM